Vertex Pharmaceuticals Inc (VRTX) |
|
Vertex Pharmaceuticals Inc Balance Sheet Annual
VRTX
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
VRTX Balance Sheets
(Annual, GAAP in millions $) |
(Dec 31 2023) 2023 |
(Dec 31 2022) 2022 |
(Dec 31 2021) 2021 |
(Dec 31 2020) 2020 |
(Dec 31 2019) 2019 |
ASSETS |
Cash & cash equivalent |
10,369.10 |
10,504.00 |
6,795.00 |
5,988.19 |
3,109.32 |
Restricted Cash and Cash Equivalents, Current |
- |
- |
- |
- |
- |
Marketable Securities, Current SH |
849.20 |
274.50 |
729.90 |
670.71 |
698.97 |
Cash
& Short-term Investments |
11,218.30 |
10,778.50 |
7,524.90 |
6,658.90 |
3,808.29 |
Accounts receivable |
1,563.40 |
1,442.20 |
1,136.80 |
885.35 |
633.52 |
Other Receivables |
- |
- |
- |
- |
- |
Notes Receivable, Current |
- |
- |
- |
- |
- |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization |
1,159.30 |
1,108.40 |
1,094.10 |
958.53 |
- |
Inventories |
738.80 |
460.60 |
353.10 |
280.78 |
167.50 |
Other Current Assets |
- |
- |
0.00 |
- |
- |
Prepaid Expense And Other Assets Current |
623.70 |
553.50 |
545.80 |
308.35 |
213.52 |
Total Current Assets |
14,144.20 |
13,234.80 |
9,560.60 |
8,133.38 |
4,822.83 |
Equipment/Property/Plant Net |
- |
- |
- |
- |
- |
Goodwill net |
1,088.00 |
1,088.00 |
1,002.20 |
1,002.16 |
1,002.16 |
Intangible Assets |
839.90 |
603.60 |
400.00 |
400.00 |
400.00 |
Long-term investments |
2,497.80 |
- |
- |
- |
- |
Notes, Loans and Financing Receivable, Net, Noncurrent LO |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net AS |
- |
- |
- |
- |
- |
Other Assets, Noncurrent |
2,057.00 |
1,632.00 |
1,206.00 |
1,009.00 |
2,093.48 |
Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
Deferred Income Tax Assets Net |
1,812.10 |
1,246.90 |
934.50 |
882.78 |
- |
Operating Lease Right Of Use Asset |
293.60 |
347.40 |
330.30 |
325.56 |
- |
Total Assets |
22,730.20 |
18,150.90 |
13,432.50 |
11,751.81 |
8,318.47 |
LIABILITIES |
Accounts Payable, Current AC |
364.90 |
303.90 |
195.00 |
155.14 |
87.61 |
Accrued Liabilities, Current AC |
2,655.30 |
2,126.70 |
1,678.60 |
1,404.97 |
1,116.91 |
Financial Instruments |
- |
- |
- |
- |
- |
Capital Lease Obligations, Current LO |
- |
- |
- |
- |
- |
Other Liabilities, Current |
527.20 |
311.50 |
268.40 |
317.42 |
130.31 |
Taxes Payable, Current, Total |
- |
- |
- |
- |
- |
Deferred Revenue, Current DE |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
Other Liabilities and Capital Lease Obligations Current |
- |
- |
- |
- |
- |
Finance Lease Liability Noncurrent |
376.10 |
430.80 |
509.80 |
539.04 |
- |
Operating Lease Liability Noncurrent |
348.60 |
379.50 |
377.40 |
350.46 |
- |
Total Current Liabilities |
3,547.40 |
2,742.10 |
2,142.00 |
1,877.53 |
1,334.83 |
Long-term debt |
- |
- |
- |
- |
- |
Capital Lease Obligations, Noncurrent LO |
- |
- |
- |
- |
- |
Convertible Subordinated Debt, Noncurrent CO |
- |
- |
- |
- |
- |
Total
Long-term Debt |
- |
- |
- |
- |
- |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Deferred Revenue, Noncurrent DE |
- |
- |
- |
- |
- |
Deferred Tax Liabilities, Net LI |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Other liabilities, Noncurrent |
1,602.40 |
1,496.10 |
1,190.50 |
1,187.46 |
898.39 |
Total Liabilities |
5,149.80 |
4,238.20 |
3,332.50 |
3,064.99 |
2,233.22 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
2.60 |
2.60 |
2.50 |
2.60 |
2.59 |
Additional Paid In Capital Common Stock |
7,449.70 |
7,386.50 |
6,880.80 |
7,894.03 |
7,937.61 |
Retained Earnings / Accumulated Deficit |
10,142.40 |
6,522.80 |
3,200.80 |
858.67 |
-1,852.98 |
Other Equity |
-14.30 |
0.80 |
15.90 |
-68.48 |
-1.97 |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
17,580.40 |
13,912.70 |
10,100.00 |
8,686.82 |
6,085.24 |
Liabilities & Stockholder's
Equity |
22,730.20 |
18,150.90 |
13,432.50 |
11,751.81 |
8,318.47 |
|
|